BAYER AG-REG (BAYN.DE) Fundamental Analysis & Valuation

FRA:BAYN • DE000BAY0017

Current stock price

38.385 EUR
-0.08 (-0.21%)
Last:

This BAYN.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. BAYN.DE Profitability Analysis

1.1 Basic Checks

  • BAYN had positive earnings in the past year.
  • BAYN had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: BAYN reported negative net income in multiple years.
  • In the past 5 years BAYN always reported a positive cash flow from operatings.
BAYN.DE Yearly Net Income VS EBIT VS OCF VS FCFBAYN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B -10B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -3.46%, BAYN is doing worse than 67.31% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -13.95%, BAYN is doing worse than 67.31% of the companies in the same industry.
Industry RankSector Rank
ROA -3.46%
ROE -13.95%
ROIC N/A
ROA(3y)-2.76%
ROA(5y)-0.83%
ROE(3y)-10.29%
ROE(5y)-3.43%
ROIC(3y)N/A
ROIC(5y)N/A
BAYN.DE Yearly ROA, ROE, ROICBAYN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • In the last couple of years the Operating Margin of BAYN has declined.
  • BAYN has a worse Gross Margin (58.76%) than 63.46% of its industry peers.
  • In the last couple of years the Gross Margin of BAYN has grown nicely.
  • The Profit Margin and Operating Margin are not available for BAYN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 58.76%
OM growth 3Y-2.05%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.15%
GM growth 5Y1.79%
BAYN.DE Yearly Profit, Operating, Gross MarginsBAYN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

1

2. BAYN.DE Health Analysis

2.1 Basic Checks

  • BAYN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for BAYN remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, BAYN has about the same amount of shares outstanding.
  • BAYN has a better debt/assets ratio than last year.
BAYN.DE Yearly Shares OutstandingBAYN.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
BAYN.DE Yearly Total Debt VS Total AssetsBAYN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • Based on the Altman-Z score of 0.76, we must say that BAYN is in the distress zone and has some risk of bankruptcy.
  • BAYN's Altman-Z score of 0.76 is on the low side compared to the rest of the industry. BAYN is outperformed by 71.15% of its industry peers.
  • The Debt to FCF ratio of BAYN is 10.93, which is on the high side as it means it would take BAYN, 10.93 years of fcf income to pay off all of its debts.
  • BAYN's Debt to FCF ratio of 10.93 is on the low side compared to the rest of the industry. BAYN is outperformed by 63.46% of its industry peers.
  • BAYN has a Debt/Equity ratio of 1.23. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 1.23, BAYN is doing worse than 71.15% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF 10.93
Altman-Z 0.76
ROIC/WACCN/A
WACC7.04%
BAYN.DE Yearly LT Debt VS Equity VS FCFBAYN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.3 Liquidity

  • BAYN has a Current Ratio of 1.01. This is a normal value and indicates that BAYN is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of BAYN (1.01) is worse than 76.92% of its industry peers.
  • BAYN has a Quick Ratio of 1.01. This is a bad value and indicates that BAYN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • BAYN has a Quick ratio of 0.63. This is amonst the worse of the industry: BAYN underperforms 82.69% of its industry peers.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 0.63
BAYN.DE Yearly Current Assets VS Current LiabilitesBAYN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

3

3. BAYN.DE Growth Analysis

3.1 Past

  • The earnings per share for BAYN have decreased by -2.77% in the last year.
  • The Earnings Per Share has been decreasing by -5.13% on average over the past years.
  • Looking at the last year, BAYN shows a decrease in Revenue. The Revenue has decreased by -2.21% in the last year.
  • The Revenue has been growing slightly by 1.94% on average over the past years.
EPS 1Y (TTM)-2.77%
EPS 3Y-14.8%
EPS 5Y-5.13%
EPS Q2Q%-40.95%
Revenue 1Y (TTM)-2.21%
Revenue growth 3Y-3.51%
Revenue growth 5Y1.94%
Sales Q2Q%-2.48%

3.2 Future

  • The Earnings Per Share is expected to grow by 4.13% on average over the next years.
  • BAYN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.62% yearly.
EPS Next Y-4.68%
EPS Next 2Y1.69%
EPS Next 3Y6.34%
EPS Next 5Y4.13%
Revenue Next Year0.65%
Revenue Next 2Y1.52%
Revenue Next 3Y2.48%
Revenue Next 5Y2.62%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BAYN.DE Yearly Revenue VS EstimatesBAYN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B 50B
BAYN.DE Yearly EPS VS EstimatesBAYN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

6

4. BAYN.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 7.82, the valuation of BAYN can be described as very cheap.
  • 98.08% of the companies in the same industry are more expensive than BAYN, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of BAYN to the average of the S&P500 Index (25.23), we can say BAYN is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 8.20, the valuation of BAYN can be described as very reasonable.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of BAYN indicates a rather cheap valuation: BAYN is cheaper than 98.08% of the companies listed in the same industry.
  • BAYN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.28.
Industry RankSector Rank
PE 7.82
Fwd PE 8.2
BAYN.DE Price Earnings VS Forward Price EarningsBAYN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BAYN is valued a bit more expensive than 63.46% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of BAYN indicates a rather cheap valuation: BAYN is cheaper than 88.46% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 10.97
EV/EBITDA 38.59
BAYN.DE Per share dataBAYN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.69%
EPS Next 3Y6.34%

0

5. BAYN.DE Dividend Analysis

5.1 Amount

  • BAYN has a yearly dividend return of 0.28%, which is pretty low.
  • Compared to an average industry Dividend Yield of 1.92, BAYN is paying slightly less dividend.
  • Compared to an average S&P500 Dividend Yield of 1.91, BAYN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.28%

5.2 History

  • The dividend of BAYN decreases each year by -46.01%.
Dividend Growth(5Y)-46.01%
Div Incr Years0
Div Non Decr Years3
BAYN.DE Yearly Dividends per shareBAYN.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • The earnings of BAYN are negative and hence is the payout ratio. BAYN will probably not be able to sustain this dividend level.
DP-3.51%
EPS Next 2Y1.69%
EPS Next 3Y6.34%
BAYN.DE Yearly Income VS Free CF VS DividendBAYN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B -10B

BAYN.DE Fundamentals: All Metrics, Ratios and Statistics

BAYER AG-REG

FRA:BAYN (3/20/2026, 7:00:00 PM)

38.385

-0.08 (-0.21%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-04
Earnings (Next)05-12
Inst Owners51.38%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap37.71B
Revenue(TTM)45.58B
Net Income(TTM)-3.62B
Analysts73.1
Price Target42.36 (10.36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.28%
Yearly Dividend0.13
Dividend Growth(5Y)-46.01%
DP-3.51%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)46.61%
Min EPS beat(2)22.06%
Max EPS beat(2)71.16%
EPS beat(4)4
Avg EPS beat(4)35.24%
Min EPS beat(4)1.86%
Max EPS beat(4)71.16%
EPS beat(8)7
Avg EPS beat(8)18.01%
EPS beat(12)9
Avg EPS beat(12)9.7%
EPS beat(16)12
Avg EPS beat(16)8.09%
Revenue beat(2)1
Avg Revenue beat(2)-0.88%
Min Revenue beat(2)-2.42%
Max Revenue beat(2)0.67%
Revenue beat(4)1
Avg Revenue beat(4)-1.34%
Min Revenue beat(4)-2.63%
Max Revenue beat(4)0.67%
Revenue beat(8)3
Avg Revenue beat(8)-1.37%
Revenue beat(12)3
Avg Revenue beat(12)-2.43%
Revenue beat(16)6
Avg Revenue beat(16)-1.51%
PT rev (1m)0%
PT rev (3m)29.98%
EPS NQ rev (1m)4.97%
EPS NQ rev (3m)5.52%
EPS NY rev (1m)-4.2%
EPS NY rev (3m)-3.83%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)1.41%
Revenue NY rev (1m)-0.2%
Revenue NY rev (3m)-0.4%
Valuation
Industry RankSector Rank
PE 7.82
Fwd PE 8.2
P/S 0.83
P/FCF 10.97
P/OCF 6.36
P/B 1.45
P/tB N/A
EV/EBITDA 38.59
EPS(TTM)4.91
EY12.79%
EPS(NY)4.68
Fwd EY12.19%
FCF(TTM)3.5
FCFY9.12%
OCF(TTM)6.03
OCFY15.71%
SpS46.39
BVpS26.41
TBVpS-23.14
PEG (NY)N/A
PEG (5Y)N/A
Graham Number54.02
Profitability
Industry RankSector Rank
ROA -3.46%
ROE -13.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 58.76%
FCFM 7.54%
ROA(3y)-2.76%
ROA(5y)-0.83%
ROE(3y)-10.29%
ROE(5y)-3.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)7.98%
ROCE(5y)8.08%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.05%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.15%
GM growth 5Y1.79%
F-Score6
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF 10.93
Debt/EBITDA 18.64
Cap/Depr 89.3%
Cap/Sales 5.46%
Interest Coverage N/A
Cash Conversion 346.9%
Profit Quality N/A
Current Ratio 1.01
Quick Ratio 0.63
Altman-Z 0.76
F-Score6
WACC7.04%
ROIC/WACCN/A
Cap/Depr(3y)49.46%
Cap/Depr(5y)55.83%
Cap/Sales(3y)5.73%
Cap/Sales(5y)5.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.77%
EPS 3Y-14.8%
EPS 5Y-5.13%
EPS Q2Q%-40.95%
EPS Next Y-4.68%
EPS Next 2Y1.69%
EPS Next 3Y6.34%
EPS Next 5Y4.13%
Revenue 1Y (TTM)-2.21%
Revenue growth 3Y-3.51%
Revenue growth 5Y1.94%
Sales Q2Q%-2.48%
Revenue Next Year0.65%
Revenue Next 2Y1.52%
Revenue Next 3Y2.48%
Revenue Next 5Y2.62%
EBIT growth 1Y-1416.9%
EBIT growth 3Y-5.49%
EBIT growth 5YN/A
EBIT Next Year55.31%
EBIT Next 3Y16.4%
EBIT Next 5Y10.93%
FCF growth 1Y-25.07%
FCF growth 3Y-6.06%
FCF growth 5Y6.77%
OCF growth 1Y-19.56%
OCF growth 3Y-5.83%
OCF growth 5Y3.89%

BAYER AG-REG / BAYN.DE Fundamental Analysis FAQ

What is the fundamental rating for BAYN stock?

ChartMill assigns a fundamental rating of 2 / 10 to BAYN.DE.


What is the valuation status of BAYER AG-REG (BAYN.DE) stock?

ChartMill assigns a valuation rating of 6 / 10 to BAYER AG-REG (BAYN.DE). This can be considered as Fairly Valued.


How profitable is BAYER AG-REG (BAYN.DE) stock?

BAYER AG-REG (BAYN.DE) has a profitability rating of 2 / 10.


How financially healthy is BAYER AG-REG?

The financial health rating of BAYER AG-REG (BAYN.DE) is 1 / 10.


How sustainable is the dividend of BAYER AG-REG (BAYN.DE) stock?

The dividend rating of BAYER AG-REG (BAYN.DE) is 0 / 10 and the dividend payout ratio is -3.51%.